Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4057
Gene Symbol: LTF
LTF
0.300 Therapeutic group CTD_human Therapeutic potential of iron chelators in diseases associated with iron mismanagement. 16640825 2006
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE All clinical outcomes analyzed were more prevalent in the juvenile forms of HH, with the exception of arthritis and arthropathy, which were more commonly seen in HFE HH. 29743178 2018
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE RESEARCH DESIGN AND METHODS We studied these 16 variables in 159 nonscreening hemochromatosis probands with HFE C282Y homozygosity: age; sex; BMI; diabetes reports in first-degree family members (dichotomous); heavy ethanol consumption; cigarette smoking; elevated serum alanine aminotransferase/aspartate aminotransferase levels; nonalcoholic fatty liver; chronic viral hepatitis; cirrhosis; hand arthropathy; iron removed by phlebotomy; and positivity for HLA-A*01, B*08; A*03, B*07; and A*03, B*14 haplotypes. 23990522 2014
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE Previous studies suggest an elevated prevalence of clinical and radiographic signs of arthropathy in patients with GH, and 2 smaller studies suggest a possibly elevated risk of joint replacement surgery, but more mixed results are shown regarding risks with HFE genotype. 23139229 2013
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE On the basis of this premise and in the light of the finding in a small observational study that HFE gene mutations are very common in precocious bilateral hip OA (100% amongst 8 sequentially collected patients), it is hypothesised that precocious bilateral hip OA is a "form-fruste" of the arthropathy of HH in which HFE gene mutation mediated articular iron deposition in hip joint tissues may be of pivotal pathogenetic importance. 19942354 2010
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE This finding is consistent with the possibility that, in OA patients with HFE gene mutations, localized iron overload may contribute either directly or indirectly to osteochondral damage, possibly in a similar way to that which occurs in the arthropathy that complicates HH. 20560808 2010
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 GeneticVariation group BEFREE .To test the hypothesis that possession of either C282Y or H63D mutations in the HFE gene is associated with primary osteoarthritis (OA) in joints commonly affected in hemochromatotic arthropathy. 16583477 2006
Entrez Id: 3077
Gene Symbol: HFE
HFE
0.160 Biomarker group HPO
Entrez Id: 10216
Gene Symbol: PRG4
PRG4
0.120 AlteredExpression group BEFREE Therefore, alterations in the subchondral bone in models with absent or diminished Prg4 expression should not be overlooked when investigating changes within the articular cartilage regarding the pathogenesis of osteoarthritis/arthrosis.© 2019 Orthopaedic Research Society. 31119776 2019
Entrez Id: 10216
Gene Symbol: PRG4
PRG4
0.120 GeneticVariation group BEFREE These findings are relevant to patients at risk for arthrosis, from camptodactyl-arthropathy-coxa vara-pericarditis (CACP) syndrome and transient lubricin insufficiency due to trauma and inflammation. 28604608 2017
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.120 GeneticVariation group BEFREE Similarly, it is under-acknowledged that COL2A1 mutations may solely cause joint disease in the absence of the other mentioned phenotypic clues. 21332586 2012
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.120 GeneticVariation group BEFREE To test for the reexpression of the chondroprogenitor splice variant of the gene COL2A1, type IIA procollagen (containing a cysteine-rich NH2 propeptide), in adult articular chondrocytes in osteoarthritic (OA) joint disease. 10403272 1999
Entrez Id: 10216
Gene Symbol: PRG4
PRG4
0.120 Biomarker group HPO
Entrez Id: 1280
Gene Symbol: COL2A1
COL2A1
0.120 Biomarker group HPO
Entrez Id: 59341
Gene Symbol: TRPV4
TRPV4
0.110 GeneticVariation group BEFREE Dominant mutations in the receptor calcium channel gene TRPV4 have been associated with a family of skeletal dysplasias (metatropic dysplasia, pseudo-Morquio type 2, spondylometaphyseal dysplasia, Kozlowski type, brachyolmia, and familial digital arthropathy) as well as with dominantly inherited neuropathies (hereditary motor and sensory neuropathy 2C, scapuloperoneal spinal muscular atrophy, and congenital distal spinal muscular atrophy). 21964829 2011
Entrez Id: 8838
Gene Symbol: CCN6
CCN6
0.110 GeneticVariation group BEFREE A homozygous recurring mutation in WISP3 causing progressive pseudorheumatoid arthropathy. 21528827 2011
Entrez Id: 25939
Gene Symbol: SAMHD1
SAMHD1
0.110 GeneticVariation group BEFREE We propose that arthropathy with progressive contractures should now be considered part of the spectrum of Aicardi-Goutières syndrome because of SAMHD1 mutations. 20358604 2010
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.110 GeneticVariation group BEFREE Multicentric osteolysis with nodulosis and arthropathy (MONA, NAO (OMIM no. 18985071 2009
Entrez Id: 56172
Gene Symbol: ANKH
ANKH
0.110 AlteredExpression group BEFREE The upregulation of ANK expression in OA cartilage and the capacity of increased ANK expression to induce MMP-13 and to promote matrix loss suggest that increased ANK expression and ecPP(i) exert noxious effects in degenerative arthropathies beyond stimulation of calcification. 15023384 2004
Entrez Id: 25939
Gene Symbol: SAMHD1
SAMHD1
0.110 Biomarker group HPO
Entrez Id: 56172
Gene Symbol: ANKH
ANKH
0.110 Biomarker group HPO
Entrez Id: 4313
Gene Symbol: MMP2
MMP2
0.110 Biomarker group HPO
Entrez Id: 8838
Gene Symbol: CCN6
CCN6
0.110 Biomarker group HPO
Entrez Id: 59341
Gene Symbol: TRPV4
TRPV4
0.110 Biomarker group HPO
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.100 Biomarker group BEFREE We assessed achievement of remission as defined by Boolean criteria, Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), and 28-joint Disease Activity Score using C-reactive protein (DAS28[CRP]) and determined the components that limit patients in SDAI, CDAI, or DAS28(CRP) remission from achieving Boolean remission. 31590930 2020